Intrasense launches its AI Hub in partnership with Milvue

Intrasense (FR0011179886 – ALINS), specialist in medical imaging software solutions, announces, in partnership with the company Milvue, the first
integration of a solution within its Hub dedicated to artificial intelligence. The AI Hub enables the simple and ergonomic integration of artificial intelligence algorithms and their orchestration within clinical applications to better meet the needs of users.

The AI Hub: artificial intelligence in clinical routine

The integration of AI into clinical routine is a major challenge today. The numerous algorithms available on the market, each covering different organs
and needs, have demonstrated their effectiveness in helping the health professional in thier diagnosis. However, to be effective, these different algorithms must intervene automatically at the right moment in the clinician’s workflow and provide them the results within their clinical tools, with possibilities of review and adjustments.

In this context, Intrasense teams have developed the AI Hub, which enables the seamless and ergonomic integration of artificial intelligence results into Intrasense clinical solutions. The AI Hub can be customized in cloud and hybrid mode, meeting users’ expectations in terms of performance and security. This differentiated approach to AI integration in the medical imaging industry allows Intrasense to offer its customers increasingly innovative tools in a fully integrated environment, while leaving users in clinical control of the algorithm results.

A first in France project with Milvue

As part of this new solution, Intrasense has integrated into the AI Hub the Milvue Suite technology from its industrial partner Milvue, a French company specialized in the development of AI algorithms. Milvue enables the automatic detection of several families of osteoarticular and pulmonary pathologies as well as the quantification of orthopaedic measurements in radiology. It is a cutting- edge tool that optimizes the triage of examinations according to their results, thus facilitates the work of radiology services.

“Artificial intelligence has become an essential support opening new perspectives to the practice of radiology today. The strength of our Myrian platform, thanks to the AI Hub, is to integrate in an optimized and adapted way the results of artificial intelligence at the very heart of the clinical applications used by healthcare professionals. This first partnership around the AI Hub, with the company Milvue, allows Intrasense to enrich its clinical catalog and thus to offer its customers increasingly relevant and efficient solutions. This project marks the beginning of a new series of partnerships aimed at further enriching our clinical offering in a dynamic market,” said Nicolas Reymond, CEO of Intrasense.

Intrasense, whose innovation remains at the core of its DNA, is the first player in its field to offer a complete solution, enabling hybrid deployments, and directly integrated within radiologists’ clinical tools. The AI Hub is now available for the Myrian® product line and will also be used in the new product line dedicated to oncology, currently under development.

“Artificial intelligence has become an essential support opening new perspectives to the practice of radiology today. The strength of our Myrian platform, thanks to the AI Hub, is to integrate in an optimized and adapted way the results of artificial intelligence at the very heart of the clinical applications used by healthcare professionals. This first partnership around the AI Hub, with the company Milvue, allows Intrasense to enrich its clinical catalog and thus to offer its customers increasingly relevant and efficient solutions. This project marks the beginning of a new series of partnerships aimed at further enriching our clinical offering in a dynamic market,” said Nicolas Reymond, CEO of Intrasense.

Intrasense, whose innovation remains at the core of its DNA, is the first player in its field to offer a complete solution, enabling hybrid deployments, and directly integrated within radiologists’ clinical tools. The AI Hub is now available for the Myrian® product line and will also be used in the new product line dedicated to oncology, currently under development.

About Intrasense

Founded in 2004, Intrasense develops and markets a unique medical device named Myrian®, a software platform facilitating and ensuring diagnosis, decision-making and therapeutic follow-up. Thanks to Myrian®, more than 1000 hospitals and clinics spread over 40 countries use a unique and integrated platform supporting all types of imaging modalities (MRI, scanner…). Enriched with expert clinical modules dedicated to specific pathologies and organs, Myrian® provides a universal medical image processing solution which can be fully integrated into any healthcare information system. Intrasense has 56 employees among which 16 are dedicated to Research & Development. Intrasense has been labelled ‘innovative company’ by the BPI and has invested more than 10 million euros in Research & Development since its creation.

More information is available at: http: //www.intrasense.fr.

Intrasense

Anne-Elisabeth Achiri

Communications Officer

investisseurs@intrasense.fr

Last News
from &nbsp
Milvue